48 results on '"Kempf, Amy"'
Search Results
2. Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
3. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
4. Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5
5. Cytoskeletal β-tubulin and cysteine cathepsin L deregulation by SARS-CoV-2 spike protein interaction with the neuronal model cell line SH-SY5Y
6. Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
7. Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
8. No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
9. Probing Scaffold Size Effects on Multivalent Lectin-Glycan Binding Affinity, Thermodynamics and Antiviral Potency Using Polyvalent Glycan-Gold Nanoparticles
10. Polyvalent Glycomimetic-Gold Nanoparticle Conjugates reveal effects of glycan display on Multivalent Lectin-Glycan Interactions
11. Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany
12. Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination
13. The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
14. Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance
15. Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination
16. Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3
17. Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
18. TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
19. Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
20. Inside Back Cover Image, Volume 95, Number 1, January 2023
21. Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
22. TMPRSS2 is essential for SARS-CoV-2 Beta and Omicron infection
23. The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
24. The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
25. Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
26. Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
27. A Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
28. Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection
29. SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
30. Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
31. Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy
32. Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
33. SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
34. Making Time for Reflection: One Teacher's Quest Toward Deeper Student Understanding
35. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
36. Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection.
37. The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic
38. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
39. SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
40. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
41. Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccination
42. Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination
43. Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination
44. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
45. SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
46. SARS-CoV-2 variants B.1.351 and B.1.1.248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination
47. Conferring with Kindergarten Writers: They're More than Just Illustrators.
48. Probing scaffold size effects on multivalent lectin-glycan binding affinity, thermodynamics and antiviral properties using polyvalent glycan-gold nanoparticles.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.